Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease

Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
J Parkinsons Dis. 2021 Mar 27. doi: 10.3233/JPD-202489. Online ahead of print.ABSTRACTAlpha-synuclein deposits are detectable in skin biopsies of patients with Parkinson's disease and other synucleinopathies like multiple system atrophy by immunohistochemical staining. As they are easily to obtain, they appear a promising tool for the pre-mortem histopathological confirmation of the disease and as a potential outcome measure in studies ... read more
Source: PubMedPublished on 2021-04-05By Kathrin Doppler